Cabinet must work harder to alert consumers to health risks of new drug products, says the Council of Canadian Academies. The warnings over ineffectual disclosure of risks comes ahead of new drug labelling regulations to take effect this week: ‘This is not insurmountable’.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
